Biography
Dr. Kiran Turaga is the Chief of the Section of Surgical Oncology at Yale and Smilow Cancer Hospital in New Haven, Connecticut. He is an expert in cytoreductive surgery with HIPEC for peritoneal surface malignancies, including peritoneal mesothelioma. Dr. Turaga holds both an MD and an MPH, reflecting his dual expertise in surgical technique and population-level outcomes research. His program at Yale represents one of the few HIPEC programs in New England outside of Boston, providing patients in Connecticut and the surrounding region access to specialized peritoneal mesothelioma treatment at a world-class academic medical center.
Education & Training
- Medical Degree — Bangalore Medical College (Medicine)
- MPH — Medical College of Wisconsin (Public Health)
- Residency — Medical College of Wisconsin (General Surgery)
- Fellowship — University of Pittsburgh Medical Center (Surgical Oncology)
Specialties & Procedures
Clinical Specialties
- Surgical Oncology
- Peritoneal Surface Malignancies
- HIPEC
Surgical Procedures
Board Certifications
- American Board of Surgery
Research Focus
HIPEC for peritoneal surface malignancies, outcomes research in peritoneal cancers, and quality of life after cytoreductive surgery.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Is Yale's HIPEC program one of the few in New England?
Yes. Dr. Turaga's HIPEC program at Yale/Smilow Cancer Hospital is one of the few specialized peritoneal surface malignancy programs in New England outside of Boston, providing important regional access for patients with peritoneal mesothelioma.